Howorth Pharma wins record containment order
Howorth Pharma, a specialist in the design and manufacture of pharmaceutical containment equipment, has been awarded a US$5m contract by an un-named client – the largest order in the company’s history.
The contract for a total of 29 barrier isolators was secured after the company demonstrated that it could provide retrofit containment solutions to a number of complex existing pharmaceutical machines. Processes such as wet granulation, tray drying, fluid bed drying, milling, capsule coating, tablet pressing and coating are features of this project.
The team at Howorth prepared detailed arrangement drawings of each barrier isolator along with predicted forecast performance data. Following preliminary approval, full-scale ergonomic mock-ups of the containment systems were constructed at Howorth’s UK facility, then shipped to the client’s facility for interface with the existing machines and subsequent review with the user groups. Any modifications were incorporated into the detail design phase and subsequent manufacture.
One unusual aspect of the project was the flexibility of the client to release the existing machines into Howorth’s possession for integration of the isolators. This resulted in significant time-savings during the eventual installation process.
During detailed engineering, Howorth designed numerous features of the isolators for commonality throughout the project. This approach provided considerable cost-savings for the client with reduced stocking of spare parts, and also ensured familiarity for the users and maintenance teams across the full range of delivered isolators. Savings were also made by updating, and thus prolonging the life of, existing production machinery, rather than rendering it obsolete.
“Howorth Pharma is delighted to have secured this contract, which must be one of the world’s largest single projects for this type of containment equipment,” said Howorth’s UK operations director, Graham Hind.